Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C30H45ClO6 |
| Molecular Weight | 537.128 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 10 / 10 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1(C)CC[C@@]2(CCC3=C([C@@H](CCl)C[C@@H]4[C@@]5(C)C[C@H](O)[C@H](O)[C@](C)([C@@H]5CC[C@@]34C)C(O)=O)[C@@H]2C1)C(O)=O
InChI
InChIKey=CWHJIJJSDGEHNS-MYLFLSLOSA-N
InChI=1S/C30H45ClO6/c1-26(2)10-11-30(25(36)37)9-6-17-22(18(30)13-26)16(15-31)12-21-27(17,3)8-7-20-28(21,4)14-19(32)23(33)29(20,5)24(34)35/h16,18-21,23,32-33H,6-15H2,1-5H3,(H,34,35)(H,36,37)/t16-,18+,19+,20-,21+,23+,27+,28+,29+,30-/m1/s1
| Molecular Formula | C30H45ClO6 |
| Molecular Weight | 537.128 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 10 / 10 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Senegenin (Tenuigenin) is a natural product from Polygala tenuifolia used in Chinese medicine to improve memory and intelligence. Senegenin attenuated hepatic ischemia-reperfusion induced cognitive dysfunction via increasing NR2B expression in rat hippocampus. Senegenin displayed antiapoptotic and antioxidative activity in hippocampal neurons due to scavenging of intracellular reactive oxygen species, regulating Bcl-2 family and suppressing caspase-3 activity. In vitro studies have indicated that senegenin treatment suppresses secretion of amyloid β protein and attenuate its cytotoxicity. Anti-inflammatory effect of senegenin is expressed via inhibition of NF-κB activation and was investigated in preclinical models of pneumonia, osteoarthritis, acute liver injury and other diseases.
CNS Activity
Originator
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: Q13224 Gene ID: 2904.0 Gene Symbol: GRIN2B Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/23029109 |
|||
Target ID: P56817|||Q9UJT5 Gene ID: 23621.0 Gene Symbol: BACE1 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/19208093 |
|||
Target ID: map04064 Sources: https://www.ncbi.nlm.nih.gov/pubmed/26846886 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | Unknown Approved UseUnknown |
|||
| Primary | Unknown Approved UseUnknown |
|||
| Primary | Unknown Approved UseUnknown |
|||
| Primary | Unknown Approved UseUnknown |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Protective effects of tenuigenin on Staphylococcus aureus-induced pneumonia in mice. | 2017-09 |
|
| Tenuigenin Prevents IL-1β-induced Inflammation in Human Osteoarthritis Chondrocytes by Suppressing PI3K/AKT/NF-κB Signaling Pathway. | 2016-04 |
|
| Senegenin attenuates hepatic ischemia-reperfusion induced cognitive dysfunction by increasing hippocampal NR2B expression in rats. | 2012 |
|
| Tenuifolin, an extract derived from tenuigenin, inhibits amyloid-beta secretion in vitro. | 2009-08 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/23029109
In a study of ischemia-reperfusion induced cognitive dysfunction in rats, senegenin was administered orally at doses 15, 30 and 60 mg/kg once per day.
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/19208093
To measure effect of senegenin on amyloid-beta secretion, COS-7 cells transfected with APP695 cDNA or the Swedish mutation (COS 695 Swe) were cultured in humidified air with tenuifolin (0.5-2.0 ug/mL). Cell media were collected after tenuifolin treatment and then diluted within the linear range of each assay. Sandwiched enzyme-linked immunosorbent assays were used to detect Ab1-40 and Ab1-42 levels following the manufacturer’s instructions. Ab was visualized using a horseradish peroxidase-conjugated anti-rabbit immunoglobulin antibody.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Tue Apr 01 16:22:24 GMT 2025
by
admin
on
Tue Apr 01 16:22:24 GMT 2025
|
| Record UNII |
06S1QH951L
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
06S1QH951L
Created by
admin on Tue Apr 01 16:22:25 GMT 2025 , Edited by admin on Tue Apr 01 16:22:25 GMT 2025
|
PRIMARY | |||
|
m461
Created by
admin on Tue Apr 01 16:22:25 GMT 2025 , Edited by admin on Tue Apr 01 16:22:25 GMT 2025
|
PRIMARY | Merck Index | ||
|
2469-34-3
Created by
admin on Tue Apr 01 16:22:25 GMT 2025 , Edited by admin on Tue Apr 01 16:22:25 GMT 2025
|
PRIMARY | |||
|
12442762
Created by
admin on Tue Apr 01 16:22:25 GMT 2025 , Edited by admin on Tue Apr 01 16:22:25 GMT 2025
|
PRIMARY | |||
|
DTXSID90947632
Created by
admin on Tue Apr 01 16:22:25 GMT 2025 , Edited by admin on Tue Apr 01 16:22:25 GMT 2025
|
PRIMARY |